GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cyberonics, Inc. (CYBX) [hlAlert]

Rating:
Strong Buy
CYBX
up 296.26 %

Cyberonics, Inc. (CYBX) rated Strong Buy with price target $60 by WBB Securities

Posted on: Wednesday,  Sep 26, 2012  9:25 AM ET by WBB Securities

WBB Securities rated Strong Buy Cyberonics, Inc. (NASDAQ: CYBX) on 09/26/2012. Previously WBB Securities rated Buy Cyberonics, Inc. (NASDAQ: CYBX) on
02/19/2010., when the stock price was $16.86. Since then, Cyberonics, Inc. has gained 296.26% as of 10/16/2016's recent price of $66.81.
If you would have followed the previous WBB Securities's recommendation on CYBX, you would have gained 296.26% of your investment in 2431 days.

Cyberonics, Inc. was founded to design, develop and market medical devices for the treatment of epilepsy and other debilitating neurological disorders using a therapy, vagus nerve stimulation. The company's initial target market is epilepsy, the world's second most prevalent neurological disorder, which is characterized by seizures. Vagus nerve stimulation with the Cyberonics NCP System was approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents with medically refractory partial onset seizures. (PRESS RELEASE)

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/26/2012 9:25 AM Buy
None
52.23 60.00
as of 12/31/2012
1 Week up  0.17 %
1 Month up  1.60 %
3 Months up  0.20 %
1 YTD up  56.80 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/3/2011 9:25 AM Buy
None
29.05
1/31/2011 9:25 AM Buy
None
33.61 38.00
2/19/2010 9:25 AM Buy
None
16.86 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy